(ECX) ECARX Holdings Ordinary - Ratings and Ratios
System-On-Chip, Central-Computing, Infotainment, Digital-Cockpit, Autonomous-Driving
ECX EPS (Earnings per Share)
ECX Revenue
Description: ECX ECARX Holdings Ordinary October 22, 2025
ECARX Holdings Inc. (NASDAQ: ECX) is a Shanghai-based developer of a full-stack automotive computing platform that spans silicon (system-on-chip), central processing units, operating systems, and integrated software for smart-mobility applications. Its product lineup includes infotainment head units, autonomous-driving control modules, digital cockpit displays, vehicle-chipset solutions, a proprietary OS, and a unified software stack. The firm was founded in 2017 and recently announced a strategic partnership with Black Sesame Technologies to accelerate AI-driven chip development.
Key quantitative signals (as of the latest public filings and market estimates) suggest ECARX generated roughly $70 million in revenue in FY 2023, with R&D expenses representing about 15 % of that total-a level consistent with peers that are heavily investing in next-generation vehicle electronics. The Chinese automotive electronics market is projected to grow at a 14-15 % compound annual growth rate through 2028, driven by rapid EV adoption and government incentives for intelligent-vehicle features, which positions ECARX’s addressable market at several tens of billions of dollars. However, the company’s exposure to China’s regulatory environment (e.g., data-localisation rules for autonomous-driving software) and the concentration of its customer base among a few domestic OEMs introduce material upside and downside uncertainty.
For a deeper quantitative assessment, the ValueRay platform provides a granular breakdown of ECX’s forward cash-flow assumptions and sensitivity analyses.
ECX Stock Overview
| Market Cap in USD | 773m |
| Sub-Industry | Automotive Parts & Equipment |
| IPO / Inception | 2022-12-20 |
ECX Stock Ratings
| Growth Rating | -41.5% |
| Fundamental | 30.1% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 8.59% |
| Analyst Rating | 5.0 of 5 |
ECX Dividends
Currently no dividends paidECX Growth Ratios
| Growth Correlation 3m | 84.7% |
| Growth Correlation 12m | -1.7% |
| Growth Correlation 5y | -84.1% |
| CAGR 5y | -38.48% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.42 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.56 |
| Sharpe Ratio 12m | -0.04 |
| Alpha | 20.19 |
| Beta | 0.697 |
| Volatility | 83.69% |
| Current Volume | 1614.4k |
| Average Volume 20d | 1465.7k |
| Stop Loss | 2.1 (-11%) |
| Signal | 0.23 |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-592.8m TTM) > 0 and > 6% of Revenue (6% = 284.6m TTM) |
| FCFTA -1.10 (>2.0%) and ΔFCFTA -110.9pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.32% (prev -31.27%; Δ 23.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.87 (>3.0%) and CFO -430.3m > Net Income -592.8m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (341.8m) change vs 12m ago 1.05% (target <= -2.0% for YES) |
| Gross Margin 19.34% (prev 24.53%; Δ -5.18pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 209.5% (prev 127.3%; Δ 82.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.64 (EBITDA TTM -552.5m / Interest Expense TTM 128.1m) >= 6 (WARN >= 3) |
Altman Z'' -15.83
| (A) -0.70 = (Total Current Assets 386.0m - Total Current Liabilities 733.2m) / Total Assets 495.2m |
| (B) -2.41 = Retained Earnings (Balance) -1.19b / Total Assets 495.2m |
| warn (B) unusual magnitude: -2.41 — check mapping/units |
| (C) -0.26 = EBIT TTM -594.4m / Avg Total Assets 2.26b |
| (D) -1.53 = Book Value of Equity -1.21b / Total Liabilities 790.4m |
| Total Rating: -15.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.12
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield -9.43% = -4.71 |
| 3. FCF Margin -11.49% = -4.31 |
| 4. Debt/Equity -1.33 = -2.50 |
| 5. Debt/Ebitda -0.56 = -2.50 |
| 7. RoE 43.54% = 2.50 |
| 8. Rev. Trend -19.94% = -1.50 |
| 9. EPS Trend -57.24% = -2.86 |
What is the price of ECX shares?
Over the past week, the price has changed by +6.79%, over one month by +11.32%, over three months by +48.43% and over the past year by +29.67%.
Is ECARX Holdings Ordinary a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ECX is around 1.86 USD . This means that ECX is currently overvalued and has a potential downside of -21.19%.
Is ECX a buy, sell or hold?
- Strong Buy: 6
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ECX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.5 | 49.6% |
| Analysts Target Price | 3.5 | 49.6% |
| ValueRay Target Price | 2.1 | -12.7% |
ECX Fundamental Data Overview October 20, 2025
P/S = 1.0218
Beta = 0.697
Revenue TTM = 4.74b CNY
EBIT TTM = -594.4m CNY
EBITDA TTM = -552.5m CNY
Long Term Debt = 21.9m CNY (from capitalLeaseObligations, last quarter)
Short Term Debt = 377.8m CNY (from shortTermDebt, last quarter)
Debt = 394.2m CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 308.0m CNY (from netDebt column, last quarter)
Enterprise Value = 5.78b CNY (5.51b + Debt 394.2m - CCE 119.6m)
Interest Coverage Ratio = -4.64 (Ebit TTM -594.4m / Interest Expense TTM 128.1m)
FCF Yield = -9.43% (FCF TTM -544.9m / Enterprise Value 5.78b)
FCF Margin = -11.49% (FCF TTM -544.9m / Revenue TTM 4.74b)
Net Margin = -12.50% (Net Income TTM -592.8m / Revenue TTM 4.74b)
Gross Margin = 19.34% ((Revenue TTM 4.74b - Cost of Revenue TTM 3.83b) / Revenue TTM)
Gross Margin QoQ = 10.80% (prev 19.84%)
Tobins Q-Ratio = 11.67 (Enterprise Value 5.78b / Total Assets 495.2m)
Interest Expense / Debt = 1.40% (Interest Expense 5.50m / Debt 394.2m)
Taxrate = -4.13% (negative due to tax credits) (1.80m / -43.6m)
NOPAT = -618.9m (EBIT -594.4m * (1 - -4.13%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.53 (Total Current Assets 386.0m / Total Current Liabilities 733.2m)
Debt / Equity = -1.33 (negative equity) (Debt 394.2m / totalStockholderEquity, last quarter -296.3m)
Debt / EBITDA = -0.56 (negative EBITDA) (Net Debt 308.0m / EBITDA -552.5m)
Debt / FCF = -0.57 (negative FCF - burning cash) (Net Debt 308.0m / FCF TTM -544.9m)
Total Stockholder Equity = -1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = -119.7% (out of range, set to none)
RoE = 43.54% (negative equity) (Net Income TTM -592.8m / Total Stockholder Equity -1.36b)
RoCE = 44.37% (negative capital employed) (EBIT -594.4m / Capital Employed (Equity -1.36b + L.T.Debt 21.9m))
RoIC = -143.9% (out of range, set to none) (NOPAT -618.9m / Invested Capital 430.0m)
WACC = 8.10% (E(5.51b)/V(5.90b) * Re(8.58%) + D(394.2m)/V(5.90b) * Rd(1.40%) * (1-Tc(-0.04)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.56%
Fair Price DCF = unknown (Cash Flow -544.9m)
EPS Correlation: -57.24 | EPS CAGR: -79.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: -19.94 | Revenue CAGR: -42.71% | SUE: -0.04 | # QB: 0
Additional Sources for ECX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle